1xbet
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
betforward
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
yasbetir1.xyz
winbet-bet.com
1kickbet1.com
1xbet-ir1.xyz
hattrickbet1.com
4shart.com
manotobet.net
hazaratir.com
takbetir2.xyz
1betcart.com
betforwardperir.xyz
betforward-shart.com
betforward.com.co
betforward.help
betfa.cam
2betboro.com
1xbete.org
1xbett.bet
romabet.cam
megapari.cam
mahbet.cam
1xbetgiris.cam
betwiner.org
betwiner.org
1xbetgiris.cam
1xbet
1xbet
alvinbet.site
alvinbet.bet
alvinbet.help
alvinbet.site
alvinbet.bet
alvinbet.help
1xbet giris
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
betwinner
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
1xbet
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
betforward
betforward
betforward
betforward
betforward
betforward
betforward
betforward
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
betforward
betforward
betforward
betforward
betforward
betforward
betforward
betforward
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
betcart
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی

Global Statistics

All countries
695,781,740
Confirmed
Updated on September 26, 2023 9:04 pm
All countries
627,110,498
Recovered
Updated on September 26, 2023 9:04 pm
All countries
6,919,573
Deaths
Updated on September 26, 2023 9:04 pm

Global Statistics

All countries
695,781,740
Confirmed
Updated on September 26, 2023 9:04 pm
All countries
627,110,498
Recovered
Updated on September 26, 2023 9:04 pm
All countries
6,919,573
Deaths
Updated on September 26, 2023 9:04 pm

Alleged Gupta ‘fixer’ Kuben Moodley reportedly fails to adhere to order, NPA heads back to court | News24

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f

Even As a Wicker Man, Alexander Skarsgård’s Got Game. This Scent Will Give You Some Too.

3 min read IF ANYONE CAN MAKE RATTAN hot, it’s Alexander Skarsgård. The actor’s latest film project, about a craftsman who creates a wicker husband (Skarsgård) for a lonely woman (played by Olivia Colman), has been an unlikely hit since its release in theaters last week. But basket weave isn’t the only material Skarsgård’s rocking—he’s

Data Center Health Worries Animate Midterm Campaigns

PAGE, Ariz. — Doug Herrera still lives in the house his father built, though his dad died some time ago from cancer. Herrera wonders if that illness could have been linked to pollutants from nearby uranium mining. Now, he worries that a possible new neighbor — a proposed $10 billion mega data center — could

Head of the National Prosecuting Authority's Investigative Directorate Hermione Cronjé.

Head of the National Prosecuting Authority’s Investigative Directorate Hermione Cronjé.

Gallo Images / Phill Magakoe

  • The Gauteng High Court in Johannesburg granted an order restraining alleged Gupta “fixer” Kuben Moodley from dealing with R232 million worth of assets.
  • It is alleged Moodley and his company received kickbacks from the Regiments Group of Companies.
  • The NPA’s Investigating Directorate filed an urgent application, alleging that Moodley failed to hand over assets as per a court order.

The National Prosecuting Authority’s Investigating Directorate (ID) has filed an urgent application for contempt of court against alleged Gupta “fixer” Kuben Moodley after he reportedly failed to hand over assets as per a court order.

In June, News24 reported that a court order was granted, which restrained Moodley and his letterbox company, Albatime, from dealing with R232 million worth of assets.

The Gauteng High Court in Johannesburg ordered that Moodley hand over his assets and barred him from using or disposing of assets held in and outside of South Africa.

In a statement on Friday, ID spokesperson Sindisiwe Twala said Moodley was expected to surrender the property.

Instead, Moodley has allegedly handed over certain assets, while withholding others.

ALSO READ | Court grants restraint order against alleged Gupta ‘fixer’ Kuben Moodley

He further allegedly refused to hand over an additional affidavit explaining what exactly was in the safety deposit boxes he kept, Twala told News24.

Twala said that, as of 6 July, the value of the assets received totalled less than 10% of the value sought.  

The initial court order, restraining R232 million worth of assets, emanates from an investigation which alleges that Moodley and his company received kickbacks from the Regiments Group of Companies relating to contracts that were improperly awarded by Transnet and by the Transnet Second Defined Benefit Fund (TSDBF). 

According to an amaBhungane investigation, Moodley introduced the chief executive of Regiments Capital, which was then an up-and-coming black-owned financial and advisory group, to businessman Salim Essa in 2012.

Following this, Essa opened doors at Transnet and other state-owned entities, where Regiments landed deals worth roughly R1 billion.

AmaBhungane reported that, for simply making the introduction, Regiments agreed to pay Moodley’s company, Albatime, up to 5% of every Essa-orchestrated deal.

News24 previously reported the ID said these kickbacks were allegedly made solely as a reward for their unlawful involvement in a corrupt scheme to benefit at the expense of the public purse.

The matter is expected to be heard on 21 July.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f

Related Articles

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f